Amino acid conjugates: Metabolites of 2-propylpentanoic acid (valproic acid) in epileptic patients

Drug Metabolism and Disposition

Volumn 31, Issue 1, 2003, Pages 114-121

  Gopaul, V S ^a,b   Tang, W ^a,c   Farrell, K ^a   Abbott, Frank S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CREATININE; UNCLASSIFIED DRUG; VALPROIC ACID; VALPROPYL GLUTAMATE; VALPROPYLGLUTAMINE; VALPROPYLGLYCINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CONJUGATION; DRUG URINE LEVEL; EPILEPSY; HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; SPECTROSCOPY; STEADY STATE;

ADOLESCENT; AMINO ACIDS; CHILD; EPILEPSY; ESTERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; VALPROIC ACID;

EID: 0038347142     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.1.114     Document Type: Article

References (34)

1. Abbott FS and Anari MR (1999) Chemistry and biotransformation, in Valproate (Löscher W, ed) pp 47-75, Birkhauser Verlag, Basel/Switzerland.
2. Adkinson K, Ojemann GA, Rapport RL, Dills RL, and Shen DD (1995) Distribution of unsaturated metabolites of valproate in human rat brain-pharmacologic relevance? Epilepsia 36:772-782.
3. Baillie TA and Sheffels PR (1995) Valproic acid. Chemistry and biotransformation, in Antiepileptic Drugs, 4th edition (Levy RH, Mattson RH, and Meldrum BS eds) pp 589-604, Raven Press, New York.
4. Caldwell J, Moffatt JR, and Smith RL (1976) Post-mortem survival of hippuric acid formation in rat and human cadaver tissue samples. Xenobiotica 6:275-280.
5. Eadie MJ, Hooper WD, and Dickinson RG (1988) Valproate-associated hepatotoxicity and its biochemical mechanisms. Med Toxicol 3:85-106.
6. Gopaul SV (1998) The Identification, Characterization, and Profiling of Novel Thiol and Amino Acid Conjugates of Valproic Acid in Humans and Animals. Ph.D. Thesis, The University of British Columbia, Vancouver, BC, Canada.
7. Gopaul SV, Farrell K, and Abbott FS (1997a) Amino acid conjugation of valproic acid in humans. ISSX Proc 11:205.
8. Gopaul SV, Tabatabaei AR, and Abbott FS (1997b) The identification of novel amino acid conjugates of valproic acid in whole brain and cerebral spinal fluid of rat and rabbit using GC/MS and LC/MS/MS. Pharma Res (NY) 14:S-355.
9. Granneman GR, Wang SI, Kesterson JW, and Machinist JM (1984a) The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 4:1153-1158.
10. Granneman GR, Wang SI, Machinist JM, and Kesterson JW (1984b) Aspects of the metabolism of valproic acid. Xenobiotica 14:375-387.
11. Harris RA, Swartzentruber M, Becker CM, McCune SA, Hu H, and Popov K (1991) Metabolic effects of sequestration of hepatic mitochondrial coenzyme A by valproate and other carboxylic acids, in Idiosyncratic Reactions to Valproate: Clinical Risk Patterns and Mechanisms of Toxicity (Levy RH and Penry JK eds) pp 97-103, Raven Press, New York.
12. Hutt AJ and Caldwell J (1990) Amino acid conjugation, in Conjugation Reactions in Drug Metabolism (Mulder GJ ed) pp 273-305, Taylor and Francis Ltd., New York.
13. Idle JR, Millburn P, and Williams RT (1975) Benzoylglutamic acid, a metabolite of benzoic acid in indian fruit bats. FEBS Lett 59:234-235.
14. Jaffe MZ (1886) Uber den Niederschlag welchen pikrinsäure in normalen Harn erzeugt and Uber eine neue Reakion des Kreatinins. Z Physiol Chem 10:391-400.
15. Jimenez-Jimenez FJ, Molina JA, Gomez P, Vargas C, de Bustos F, Benito-Leon J, Tallon-Barranco A, Orti-Pareja M, Gasalla T, and Arenas J (1998) Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. J Neural Transm 105:269-277.
16. Kälviäinen R, Halonen T, Pitkänen A, and Reikkinen P (1993) Amino acids levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. J Neurochem 60:1244-1250.
17. Kasuya F, Igarashi K, and Fukui M (1999) Characterization of a renal medium chain acyl-COA synthetase responsible for glycine conjugation in mouse mitochondria. Chem Biol Interact 118:233-246.
18. Lösher W, Nau H, and Siemes H (1988) Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy. Epilepsia 29:311-316.
19. Mawal Y, Paradis K, and Quereshi JA (1997) Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J Pediatr 130:1003-1007.
20. Mutlib AE, Shockcor J, Chen SY, Espina RJ, Pinto DJ, Orwat MJ, Prakash SR, and Gan LS (2002) Disposition of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2′-(methylsulfonyl)-[1, 1′-biphenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metaboites by liquid chromatography/mass spectrometry and NMR. Chem Res Toxicol 15:48-62.
21. Mutlib AE, Shockcor J, Espina R, Graciana N, Du A, and Gan LS (2000) Disposition of glutathione conjugates in rats by a novel glutamic pathway. Characterization of unique peptide conjugates by LC/MS and LC/NMR. J Pharmacol Exp Ther 294:735-745.
22. Perry TL and Hansen S (1981) Amino acid abnormalities in epileptogenic foci. Neurology 31:872-876.
23. Pollack GM, McHugh WB, Gengo FM, Ermer JC, and Shen DD (1986) Accumulation and washout kinetics of valproic acid and its active metabolites. J Clin Pharmacol 26:668-676.
24. Radatz M and Nau H (1999) Toxicity, in Valproate (Löscher W ed) pp 91-128, Birkhauser Verlag, Basel/Switzerland.
25. Scism JL, Powers KM, Artru AA, Lewis L, and Shen DD (2000) Probenicid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study. Brain Res 884:77-86.
26. Shirley NA, Guan X, Kaiser GW, Halstead GW, and Baillie TA (1994) Taurine conjugation of Ibuprofen in humans and rat in liver in vitro. J Pharmacol Exp Ther 269:1166-1175.
27. Smith JN (1962) Detoxications of aromatics acids with glutamic acid and arginine in spiders. Nature (Lond) 195:399-400.
28. Tang W, Palaty J, and Abbott FS (1997) Time course of α-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal γ-aminobutyric acid levels in comparison to valproic acid. J Pharmacol Exp Ther 282:1163-1172.
29. Temellini A, Mogavero S, Giulianotti PC, Pietrabissa A, Mosca F, and Pacifici GM (1993) Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica 23:1427-1433.
30. Tishler SL and Goldman P (1970) Properties and reactions of salicyl-coenzyme A Biochem Pharmacol 19:143-150.
31. Turnbull DM, Bone AJ, Barlett K, Koundakjian PP, and Sherratt HS (1983) The effects of valproate intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem Pharmacol 32:1887-1892.
32. Vajda FJE, Donnan GA, Phillips J, and Bladin PF (1981) Human brain, plasma and cerbrospinal fluid concentration of sodium valproate after 72 hours of therapy. Neurology 31:486-587.
33. Webster LT, Siddiqui UA, Lucas SV, Strong JM, and Mieyal JJ (1976) Identification of separate acyl-CoA:glycine and acyl-CoA:1-glutamine N-acyltransferase activities in mitochondrial fractions of rhesus monkey and man. J Biol Chem 251:3352-3358.
34. Williams DA (1989) Drug metabolism, in Principles of Medicinal Chemistry (Foye WO ed) 3rd edition, pp 100-102, Lea & Febiger, London.